Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Critical Mineral Executive Order Issued by President Donald Trump (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sanofi 2 ADR Representing Ord Shs SNY

Healthcare Biotechnology
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SNY)

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

PR Newswire 10 days ago

Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD

GlobeNewswire March 8, 2025

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn's Disease

GlobeNewswire February 22, 2025

Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)

GlobeNewswire November 15, 2024

Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis

GlobeNewswire November 6, 2024

Beyfortus® immunization to protect infants from RSV has begun

Canada NewsWire October 28, 2024

FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals

PR Newswire October 16, 2024

Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies

PR Newswire October 16, 2024

Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD

GlobeNewswire September 27, 2024
View More News ››

Opinion & Analysis (NDAQ:SNY)

Translate Bio and Sanofi Expand Partnership to Develop mRNA Vaccines

Streetwise Reports June 24, 2020

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Streetwise Reports September 24, 2019
View More Opinion ››

Bullboard Posts (NDAQ:SNY)

Presse release: Jean-Paul Kress to join Sanofi's Board of Di

Breaking News: $SNYNF Presse release: Jean-Paul Kress to join Sanofi's Board of DirectorsJean-Paul Kress to join Sanofi's Board...
whytestocks - December 19, 2024

Press Release: Sarclisa recommended for EU approval by the C

JUST IN: $SNYNF Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple...
whytestocks - November 14, 2024

Press Release: Sanofi and Biovac spearhead polio vaccine man

News; $SNYNF Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in AfricaSanofi and Biovac spearhead...
whytestocks - June 20, 2024

Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sal

Breaking News: $SNY Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings | BenzingaThursday,@Sanofi SA@...
whytestocks - April 25, 2024

Sanofi and Covid19? WPD Pharma...

Sanofi could easily buy WPD Pharma, who develop a Covid19-drug called WP1122. Did you read this? https://www.globenewswire.com/news...
Blocky - January 8, 2021

Happy new year Do your Own DD

https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
Rossaporino - January 2, 2021
View more Bullboard ››

Sparta Capital Ltd.

Sparta Capital Ltd.

Sparta Capital Ltd. is a technology-based company. The Company is focused on integrating emerging technologies. The Company ...
View More »